Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
5.91
-0.25 (-4.14%)
At close: May 30, 2025, 4:00 PM
5.93
+0.02 (0.42%)
After-hours: May 30, 2025, 4:04 PM EDT
Enanta Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Enanta Pharmaceuticals stock ranges from a low of $10 to a high of $21. The average analyst price target of $17.25 forecasts a 192.13% increase in the stock price over the next year.
Price Target: $17.25 (+192.13%)
Analyst Consensus: Buy
* Price targets were last updated on Feb 11, 2025.
Analyst Ratings
The average analyst rating for Enanta Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $21 | Buy | Reiterates | $21 | +255.63% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +204.83% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $18 | Strong Buy | Maintains | $27 → $18 | +204.83% | Dec 24, 2024 |
| Baird | Baird | Buy Maintains $26 → $20 | Buy | Maintains | $26 → $20 | +238.70% | Nov 26, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $22 → $21 | Buy | Reiterates | $22 → $21 | +255.63% | Nov 26, 2024 |
Financial Forecast
Revenue This Year
63.26M
from 67.64M
Decreased by -6.47%
Revenue Next Year
56.66M
from 63.26M
Decreased by -10.44%
EPS This Year
-4.36
from -5.48
EPS Next Year
-4.36
from -4.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 68.8M | 73.4M | 69.7M | ||
| Avg | 63.3M | 56.7M | 48.0M | ||
| Low | 56.8M | 32.3M | 30.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.7% | 16.0% | 23.1% | ||
| Avg | -6.5% | -10.4% | -15.2% | ||
| Low | -16.0% | -48.9% | -46.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.70 | -2.21 | -1.47 | ||
| Avg | -4.36 | -4.36 | -4.40 | ||
| Low | -6.16 | -9.31 | -9.60 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.